Table 4.
Univariate survival analysis of PFS and OS in 70 patients with endometrial carcinoma.
| Variable | Number | Estimated 5-year PFS (%) |
P*-value | Estimated 5-year OS (%) |
P*-value |
|---|---|---|---|---|---|
| Age (years) | 0.198 | 0.881 | |||
| ≤60 | 22 | 68.2 | 77.3 | ||
| >60 | 48 | 82.4 | 80.9 | ||
| FIGO stage | <0.001 | 0.016 | |||
| I + II | 39 | 94.7 | 89.7 | ||
| III + IV | 31 | 56.1 | 66.7 | ||
| Grade | 0.007 | 0.016 | |||
| G1 | 30 | 93.3 | 93.3 | ||
| G2 + G3 | 40 | 65.3 | 69.2 | ||
| Lymph node metastasis | 0.011 | 0.010 | |||
| Negative | 49 | 85.0 | 87.8 | ||
| Positive | 21 | 60.0 | 60.0 | ||
| Depth of myometrial invasion | 0.005 | 0.051 | |||
| ≤1/2 | 31 | 92.9 | 90.3 | ||
| >1/2 | 39 | 65.6 | 71.1 | ||
| LVS involvement | <0.001 | <0.001 | |||
| Negative | 44 | 92.9 | 95.5 | ||
| Positive | 26 | 50.6 | 52.0 | ||
| Peritoneal cytology | <0.001 | <0.001 | |||
| Negative | 53 | 92.2 | 92.5 | ||
| Positive | 17 | 27.3 | 37.5 | ||
| Wnt7a | 0.005 | 0.042 | |||
| Negative | 44 | 66.5 | 72.1 | ||
| Positive | 26 | 96.0 | 92.3 |
FIGO: International Federation of Gynecology and Obstertics; LVS: lymph vascular space; PFS: progression-free survival; OS: overall survival and *log-rank test.